Medibio Limited (MDBIF)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | - | 22.07 Thousand | 40.03 Thousand | 101.65 Thousand | 133.5 Thousand | 364.62 Thousand |
| Cost of Revenue | 93.13 Thousand | 1.17 Million | 1070.00 | 170.7 Thousand | 204.68 Thousand | 226.09 Thousand |
| Gross Profit | -93.13 Thousand | -1.15 Million | 38.96 Thousand | -69.04 Thousand | -71.18 Thousand | 138.53 Thousand |
| Operating Expenses | 2.02 Million | 1.52 Million | 3.67 Million | 2.56 Million | 4.56 Million | 10.47 Million |
| Selling, General and Administrative Expenses | 2 Million | 1.21 Million | 1.42 Million | 1.19 Million | 1.86 Million | 4.53 Million |
| Research and Development Expenses | 14.27 Thousand | 307.14 Thousand | 802.89 Thousand | 430.77 Thousand | 359.95 Thousand | 394.9 Thousand |
| Other Expenses | - | 938.37 Thousand | 967.68 Thousand | 1.16 Million | 791.76 Thousand | 3.76 Million |
| Cost and Expenses | 2.11 Million | 2.69 Million | 3.67 Million | 2.73 Million | 4.76 Million | 10.7 Million |
| Operating Income | -2.11 Million | -2.67 Million | -2.67 Million | -1.48 Million | -3.83 Million | -6.57 Million |
| Interest Expense | 13.44 Thousand | 13.26 Thousand | 8691.00 | 6291.00 | 36.68 Thousand | 13.92 Thousand |
| Income Tax Expense | -2.00 | -938.37 Thousand | 976.37 Thousand | 1.16 Million | 828.45 Thousand | 2.47 Million |
| Earnings before Tax | -1.23 Million | -4 Million | -12.71 Million | -1.48 Million | -3.87 Million | -6.58 Million |
| Net Income | -1.23 Million | -3.07 Million | -12.71 Million | -1.48 Million | -3.87 Million | -6.58 Million |
| Earnings Per Share Basic | -0.00 | -0.02 | -0.12 | -0.02 | -0.09 | -0.59 |
| Earnings Per Share Diluted | -0.00 | -0.02 | -0.12 | -0.02 | -0.09 | -0.59 |
| Weighted Average Shares Outstanding | 309.27 Million | 177.58 Million | 102.51 Million | 73.58 Million | 44.12 Million | 11.13 Million |
| Weighted Average Shares Outstanding (Diluted) | 309.27 Million | 177.58 Million | 102.51 Million | 73.58 Million | 44.12 Million | 11.13 Million |
| Gross Margin | - | -52.29 | 0.97 | -0.68 | -0.53 | 0.38 |
| EBIT Margin | - | -96.79 | -55.49 | -12.61 | -27.62 | -18.03 |
| Profit Margin | - | -139.10 | -317.59 | -14.62 | -29.01 | -18.07 |
| EBITDA | -2.02 Million | -2.51 Million | -2.22 Million | -1.28 Million | -3.69 Million | -6.57 Million |
| Earnings Before Tax Margin | - | -121.30 | -66.70 | -14.56 | -28.73 | -18.03 |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 9566.00 | 9566.00 | 22.07 Thousand | 293.00 |
| Cost of Revenue | 93.13 Thousand | 46.35 Thousand | 46.78 Thousand | - | 1.17 Million | 1.00 |
| Gross Profit | -93.13 Thousand | -46.35 Thousand | -37.21 Thousand | 9566.00 | -1.15 Million | 292.00 |
| Operating Expenses | 2.02 Million | 977.58 Thousand | 1.02 Million | 546.51 Thousand | 1.52 Million | 1.05 Million |
| Selling, General and Administrative Expenses | - | 966.32 Thousand | 1.04 Million | 174.27 Thousand | - | 964.03 Thousand |
| Research and Development Expenses | - | 11.26 Thousand | 3011.00 | 1506.00 | - | 90.22 Thousand |
| Other Expenses | - | - | 19.13 Thousand | - | 938.37 Thousand | - |
| Cost and Expenses | 2.11 Million | 1.02 Million | 1.07 Million | 546.51 Thousand | 2.69 Million | 1.32 Million |
| Operating Income | -2.11 Million | -1.02 Million | -1.07 Million | -536.94 Thousand | -2.67 Million | -1.32 Million |
| Interest Expense | 13.44 Thousand | - | 13.87 Thousand | - | 13.26 Thousand | 3312.00 |
| Income Tax Expense | -2.00 | -2.00 | -1.00 | - | -938.37 Thousand | -3.00 |
| Earnings before Tax | -1.23 Million | -151.59 Thousand | -1.08 Million | -542.75 Thousand | -4 Million | -2.64 Million |
| Net Income | -1.23 Million | -151.59 Thousand | -1.08 Million | -542.75 Thousand | -3.07 Million | -2.64 Million |
| Earnings Per Share Basic | - | -0.00 | -0.00 | -0.00 | - | -0.01 |
| Earnings Per Share Diluted | - | -0.00 | -0.00 | -0.00 | - | -0.01 |
| Weighted Average Shares Outstanding | 309.27 Million | 309.27 Million | 306.29 Million | 306.29 Million | 177.58 Million | 181.23 Million |
| Weighted Average Shares Outstanding (Diluted) | 309.27 Million | 309.27 Million | 306.29 Million | 306.22 Million | 177.58 Million | 181.23 Million |
| Gross Margin | - | - | -3.89 | 1.00 | -52.29 | 1.00 |
| EBIT Margin | - | - | -107.37 | -53.69 | - | -3597.17 |
| Profit Margin | - | - | -113.48 | -56.74 | -139.10 | -9043.84 |
| EBITDA | - | -977.59 Thousand | -1.02 Million | -513.55 Thousand | - | -1.05 Million |
| Earnings Before Tax Margin | - | - | -112.26 | -56.13 | -121.30 | -4533.89 |
TAKE
BLUEDART
PICCASUG
TIINDIA
SAHYADRI
WFG